William N. Kelly, PharmD

Antimicrobial stewardship programs have been around for some time. However, a tipping point has yet to be achieved where most hospitals and long-term care facilities have effective programs.

This article reviews current drug therapies for heart failure and therapy integration into a patient care framework improving patient adherence, quality of life, and decreased risk of readmission to acute care facilities.

In this case study, the authors illustrate the diagnosis of institutional antibiotic resistance issues and drivers, and provide tailored recommendations for simultaneously reducing resistance, antibiotic costs, and treatment failure.